or Try an Advanced Search...

    Technical Analysis for NYXH - Nyxoah SA

    Grade Last Price % Change Price Change
    D 10.53 -0.67% -0.07
    NYXH closed down 1.4 percent on Monday, April 22, 2024, on 38 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Up
    Historical NYXH trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction -0.67%
    Narrow Range Bar Range Contraction -0.67%
    Wide Bands Range Expansion -0.67%
    Multiple of Ten Bullish Other -2.06%
    Outside Day Range Expansion -2.06%
    Wide Bands Range Expansion -2.06%
    Up 3 Days in a Row Strength -2.06%
    Up 4 Days in a Row Strength -2.06%
    Gapped Down Weakness -2.06%
    Multiple of Ten Bullish Other 1.24%
    Older End-of-Day Signals for NYXH ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown 35 minutes ago
    Down 1% 35 minutes ago
    Rose Above Previous Day's High about 1 hour ago
    20 DMA Resistance about 1 hour ago
    1.5x Volume Pace about 1 hour ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    NYXH Chart by TradingView
    Basic chart:

    Profile

    Nyxoah is a pioneering medical device company developing a breakthrough therapeutic solution for the treatment of Obstructive Sleep Apnea (OSA). Nyxoah’s team is driven by the vision that OSA sufferers should benefit from the latest and greatest innovations, for better health outcomes, higher patient comfort and quality of life. At the heart of Nyxoah’s innovation is a unique neurostimulation technology with more than 160 patents submitted worldwide.
    Classification
    Sector: Healthcare
    Industry: Medical Instruments & Supplies
    Keywords: Medicine Clinical Medicine Sleep Apnea Sleep Disorders Obstructive Sleep Apnea Neurostimulation Technology Osa

    Is NYXH a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 11 Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer
    Mar 29 Information on the total number of voting rights and shares
    Mar 19 Nyxoah says Genio pivotal study meets primary endpoints
    Mar 19 Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints
    Mar 7 Nyxoah S.A. (NASDAQ:NYXH) Q4 2023 Earnings Call Transcript
    Mar 5 Nyxoah S.A. (NYXH) Q4 2023 Earnings Call Transcript
    Mar 5 Nyxoah SA (NYXH) Reports Q4 Loss, Misses Revenue Estimates
    Mar 5 Nyxoah GAAP EPS of -$0.37 beats by $0.04, revenue of $1.83M misses by $0.12M
    Mar 5 Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating Results
    Mar 5 Stifel Maintains Buy Rating for Nyxoah: Here's What You Need To Know
    See more NYXH news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 20.0
    52 Week Low 4.0016
    Average Volume 49,770
    200-Day Moving Average 8.42
    50-Day Moving Average 13.54
    20-Day Moving Average 11.28
    10-Day Moving Average 10.01
    Average True Range 1.23
    RSI (14) 43.18
    ADX 20.99
    +DI 18.92
    -DI 25.95
    Chandelier Exit (Long, 3 ATRs) 12.11
    Chandelier Exit (Short, 3 ATRs) 11.97
    Upper Bollinger Bands 14.26
    Lower Bollinger Band 8.31
    Percent B (%b) 0.39
    BandWidth 52.76
    MACD Line -1.05
    MACD Signal Line -1.04
    MACD Histogram -0.0101
    Fundamentals Value
    Market Cap 303.94 Million
    Num Shares 28.7 Million
    EPS -1.81
    Price-to-Earnings (P/E) Ratio -5.86
    Price-to-Sales 94.38
    Price-to-Book 2.89
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 11.41
    Resistance 3 (R3) 11.42 11.16 11.28
    Resistance 2 (R2) 11.16 10.95 11.16 11.23
    Resistance 1 (R1) 10.88 10.83 11.02 10.87 11.18
    Pivot Point 10.62 10.62 10.69 10.62 10.62
    Support 1 (S1) 10.34 10.41 10.48 10.33 10.02
    Support 2 (S2) 10.08 10.29 10.08 9.97
    Support 3 (S3) 9.80 10.08 9.93
    Support 4 (S4) 9.79